Detalhe da pesquisa
1.
Identification and evolution of a diterpenoid phytoalexin oryzalactone biosynthetic gene in the genus Oryza.
Plant J
; 118(2): 358-372, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38194491
2.
Adjuvant S-1 compared with observation in resected biliary tract cancer (JCOG1202, ASCOT): a multicentre, open-label, randomised, controlled, phase 3 trial.
Lancet
; 401(10372): 195-203, 2023 01 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-36681415
3.
Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet
; 401(10391): 1853-1865, 2023 06 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-37075781
4.
Early Tumor Shrinkage and Depth of Response as Predictors of Survival for Advanced Biliary Tract Cancer: An Exploratory Analysis of JCOG1113.
Oncologist
; 29(1): e97-e107, 2024 Jan 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37531645
5.
Phase 2 trial of bintrafusp alfa as second-line therapy for patients with locally advanced/metastatic biliary tract cancers.
Hepatology
; 78(3): 758-770, 2023 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36999533
6.
A multi-institutional randomized phase III study comparing minimally invasive distal pancreatectomy versus open distal pancreatectomy for pancreatic cancer; Japan Clinical Oncology Group study JCOG2202 (LAPAN study).
BMC Cancer
; 24(1): 231, 2024 Feb 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-38373949
7.
Progression pattern and post-progression survival following atezolizumab and bevacizumab treatment in advanced hepatocellular carcinoma.
Liver Int
; 44(6): 1343-1350, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38436529
8.
Brightline-2: a phase IIa/IIb trial of brigimadlin (BI 907828) in advanced biliary tract cancer, pancreatic ductal adenocarcinoma or other solid tumors.
Future Oncol
; 2024 Jan 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38214149
9.
Phase II trial of niraparib for BRCA-mutated biliary tract, pancreatic and other gastrointestinal cancers: NIR-B.
Future Oncol
; 2024 Apr 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-38629456
10.
The correlation between immune-related adverse events and efficacy of immune checkpoint inhibitors.
Jpn J Clin Oncol
; 2024 May 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38769817
11.
Multicenter validation study of a treatment selection MAP for pancreatic neuroendocrine tumors.
Jpn J Clin Oncol
; 2024 Apr 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-38677983
12.
Evaluation of pancreatic cancer specimens for comprehensive genomic profiling.
Pathol Int
; 74(5): 252-261, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38477638
13.
Liposomal irinotecan plus fluorouracil/leucovorin in older patients with advanced pancreatic cancer: a single-center retrospective study.
Int J Clin Oncol
; 29(2): 188-194, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37991558
14.
Clinical significance of circulating-tumour DNA analysis by metastatic sites in pancreatic cancer.
Br J Cancer
; 128(8): 1603-1608, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36782009
15.
Association Between Immune-Related Adverse Events and Survival in Patients with Hepatocellular Carcinoma Treated With Atezolizumab Plus Bevacizumab.
Oncologist
; 28(7): e526-e533, 2023 07 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37023703
16.
A Multicenter Survey on Eligibility for a Randomized Phase III Trial of Adjuvant Chemotherapy for Resected Biliary Tract Cancer (JCOG1202, ASCOT).
Ann Surg Oncol
; 30(12): 7331-7337, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37450093
17.
A prospective multicenter phase II study of FOLFIRINOX as a first-line treatment for patients with advanced and recurrent biliary tract cancer.
Invest New Drugs
; 41(1): 76-85, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36459291
18.
FOLFOX regimen after failure of fluorouracil and leucovorin plus nanoliposomal-irinotecan therapy for advanced pancreatic cancer: a retrospective observational study.
BMC Cancer
; 23(1): 177, 2023 Feb 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-36809997
19.
Liposomal irinotecan with fluorouracil and leucovorin after gemcitabine-based therapy in Japanese patients with metastatic pancreatic cancer: additional safety analysis of a randomized phase 2 trial.
Jpn J Clin Oncol
; 53(2): 130-137, 2023 Jan 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-36412114
20.
Adjuvant and neoadjuvant chemotherapy for biliary tract cancer: a review of randomized controlled trials.
Jpn J Clin Oncol
; 53(11): 1019-1026, 2023 Nov 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37599063